PACS GROUP INC (PACS) Fundamental Analysis & Valuation

NYSE:PACS • US69380Q1076

Current stock price

33.44 USD
-1.2 (-3.46%)
At close:
33.44 USD
0 (0%)
After Hours:

This PACS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. PACS Profitability Analysis

1.1 Basic Checks

  • In the past year PACS was profitable.
  • In the past year PACS had a positive cash flow from operations.
  • Each year in the past 5 years PACS has been profitable.
  • Each year in the past 5 years PACS had a positive operating cash flow.
PACS Yearly Net Income VS EBIT VS OCF VS FCFPACS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • PACS's Return On Assets of 3.43% is fine compared to the rest of the industry. PACS outperforms 66.34% of its industry peers.
  • With an excellent Return On Equity value of 20.23%, PACS belongs to the best of the industry, outperforming 88.12% of the companies in the same industry.
  • PACS has a Return On Invested Capital (4.11%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for PACS is significantly below the industry average of 8.86%.
  • The 3 year average ROIC (3.34%) for PACS is below the current ROIC(4.11%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.43%
ROE 20.23%
ROIC 4.11%
ROA(3y)2.57%
ROA(5y)N/A
ROE(3y)48.5%
ROE(5y)N/A
ROIC(3y)3.34%
ROIC(5y)N/A
PACS Yearly ROA, ROE, ROICPACS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 50 100 150 200

1.3 Margins

  • PACS has a Profit Margin of 3.62%. This is in the better half of the industry: PACS outperforms 73.27% of its industry peers.
  • PACS's Profit Margin has declined in the last couple of years.
  • PACS's Operating Margin of 5.85% is fine compared to the rest of the industry. PACS outperforms 66.34% of its industry peers.
  • PACS's Operating Margin has declined in the last couple of years.
  • The Gross Margin of PACS (21.92%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of PACS has declined.
Industry RankSector Rank
OM 5.85%
PM (TTM) 3.62%
GM 21.92%
OM growth 3Y-14.82%
OM growth 5YN/A
PM growth 3Y-16.47%
PM growth 5YN/A
GM growth 3Y-1.81%
GM growth 5YN/A
PACS Yearly Profit, Operating, Gross MarginsPACS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. PACS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PACS is destroying value.
  • The number of shares outstanding for PACS has been increased compared to 1 year ago.
  • The debt/assets ratio for PACS has been reduced compared to a year ago.
PACS Yearly Shares OutstandingPACS Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
PACS Yearly Total Debt VS Total AssetsPACS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • PACS has an Altman-Z score of 1.90. This is not the best score and indicates that PACS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • PACS has a Altman-Z score (1.90) which is in line with its industry peers.
  • PACS has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.69, PACS is in the better half of the industry, outperforming 79.21% of the companies in the same industry.
  • A Debt/Equity ratio of 0.50 indicates that PACS is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.50, PACS is in the better half of the industry, outperforming 63.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 1.69
Altman-Z 1.9
ROIC/WACC0.48
WACC8.63%
PACS Yearly LT Debt VS Equity VS FCFPACS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • PACS has a Current Ratio of 1.07. This is a normal value and indicates that PACS is financially healthy and should not expect problems in meeting its short term obligations.
  • PACS has a Current ratio of 1.07. This is in the lower half of the industry: PACS underperforms 62.38% of its industry peers.
  • A Quick Ratio of 1.07 indicates that PACS should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.07, PACS perfoms like the industry average, outperforming 42.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07
PACS Yearly Current Assets VS Current LiabilitesPACS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. PACS Growth Analysis

3.1 Past

  • PACS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.52%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 6.28% on average over the past years.
  • PACS shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.32%.
  • Measured over the past years, PACS shows a very strong growth in Revenue. The Revenue has been growing by 29.74% on average per year.
EPS 1Y (TTM)64.52%
EPS 3Y6.28%
EPS 5YN/A
EPS Q2Q%200.87%
Revenue 1Y (TTM)29.32%
Revenue growth 3Y29.74%
Revenue growth 5YN/A
Sales Q2Q%12.43%

3.2 Future

  • PACS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.72% yearly.
  • The Revenue is expected to grow by 7.78% on average over the next years.
EPS Next Y9.98%
EPS Next 2Y10.97%
EPS Next 3Y9.72%
EPS Next 5YN/A
Revenue Next Year7.53%
Revenue Next 2Y8.04%
Revenue Next 3Y7.78%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PACS Yearly Revenue VS EstimatesPACS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
PACS Yearly EPS VS EstimatesPACS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

5

4. PACS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.69 indicates a rather expensive valuation of PACS.
  • 69.31% of the companies in the same industry are more expensive than PACS, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.23. PACS is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 16.07, PACS is valued correctly.
  • 69.31% of the companies in the same industry are more expensive than PACS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.42, PACS is valued a bit cheaper.
Industry RankSector Rank
PE 17.69
Fwd PE 16.07
PACS Price Earnings VS Forward Price EarningsPACS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PACS is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PACS indicates a somewhat cheap valuation: PACS is cheaper than 64.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.59
EV/EBITDA 15.23
PACS Per share dataPACS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • PACS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • PACS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.77
PEG (5Y)N/A
EPS Next 2Y10.97%
EPS Next 3Y9.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PACS Dividend Analysis

5.1 Amount

  • PACS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PACS Fundamentals: All Metrics, Ratios and Statistics

PACS GROUP INC

NYSE:PACS (3/20/2026, 8:15:58 PM)

After market: 33.44 0 (0%)

33.44

-1.2 (-3.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners29.15%
Inst Owner Change4.38%
Ins Owners70.98%
Ins Owner Change0.28%
Market Cap5.26B
Revenue(TTM)5.29B
Net Income(TTM)191.54M
Analysts83.33
Price Target40.63 (21.5%)
Short Float %8.8%
Short Ratio3.71
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.28%
Min EPS beat(2)8.66%
Max EPS beat(2)45.9%
EPS beat(4)3
Avg EPS beat(4)12.75%
Min EPS beat(4)-16.89%
Max EPS beat(4)45.9%
EPS beat(8)5
Avg EPS beat(8)-0.54%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.05%
Min Revenue beat(2)-3.76%
Max Revenue beat(2)13.85%
Revenue beat(4)3
Avg Revenue beat(4)9.19%
Min Revenue beat(4)-3.76%
Max Revenue beat(4)13.85%
Revenue beat(8)7
Avg Revenue beat(8)7.58%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)29.54%
EPS NQ rev (1m)2.52%
EPS NQ rev (3m)1.88%
EPS NY rev (1m)0.59%
EPS NY rev (3m)-3.16%
Revenue NQ rev (1m)-1.14%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE 17.69
Fwd PE 16.07
P/S 0.99
P/FCF 17.59
P/OCF 13
P/B 5.55
P/tB 5.98
EV/EBITDA 15.23
EPS(TTM)1.89
EY5.65%
EPS(NY)2.08
Fwd EY6.22%
FCF(TTM)1.9
FCFY5.69%
OCF(TTM)2.57
OCFY7.69%
SpS33.65
BVpS6.02
TBVpS5.59
PEG (NY)1.77
PEG (5Y)N/A
Graham Number16.01
Profitability
Industry RankSector Rank
ROA 3.43%
ROE 20.23%
ROCE 6.76%
ROIC 4.11%
ROICexc 4.3%
ROICexgc 4.37%
OM 5.85%
PM (TTM) 3.62%
GM 21.92%
FCFM 5.65%
ROA(3y)2.57%
ROA(5y)N/A
ROE(3y)48.5%
ROE(5y)N/A
ROIC(3y)3.34%
ROIC(5y)N/A
ROICexc(3y)3.46%
ROICexc(5y)N/A
ROICexgc(3y)3.52%
ROICexgc(5y)N/A
ROCE(3y)5.48%
ROCE(5y)N/A
ROICexgc growth 3Y-16.56%
ROICexgc growth 5YN/A
ROICexc growth 3Y-16.09%
ROICexc growth 5YN/A
OM growth 3Y-14.82%
OM growth 5YN/A
PM growth 3Y-16.47%
PM growth 5YN/A
GM growth 3Y-1.81%
GM growth 5YN/A
F-Score7
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 1.69
Debt/EBITDA 1.29
Cap/Depr 189.36%
Cap/Sales 1.99%
Interest Coverage 7.64
Cash Conversion 110.67%
Profit Quality 156.01%
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z 1.9
F-Score7
WACC8.63%
ROIC/WACC0.48
Cap/Depr(3y)176.95%
Cap/Depr(5y)473.61%
Cap/Sales(3y)1.7%
Cap/Sales(5y)3.33%
Profit Quality(3y)237.16%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.52%
EPS 3Y6.28%
EPS 5YN/A
EPS Q2Q%200.87%
EPS Next Y9.98%
EPS Next 2Y10.97%
EPS Next 3Y9.72%
EPS Next 5YN/A
Revenue 1Y (TTM)29.32%
Revenue growth 3Y29.74%
Revenue growth 5YN/A
Sales Q2Q%12.43%
Revenue Next Year7.53%
Revenue Next 2Y8.04%
Revenue Next 3Y7.78%
Revenue Next 5YN/A
EBIT growth 1Y151.55%
EBIT growth 3Y10.52%
EBIT growth 5YN/A
EBIT Next Year34.35%
EBIT Next 3Y15.64%
EBIT Next 5YN/A
FCF growth 1Y-0.68%
FCF growth 3Y62.41%
FCF growth 5YN/A
OCF growth 1Y10.04%
OCF growth 3Y63.42%
OCF growth 5YN/A

PACS GROUP INC / PACS Fundamental Analysis FAQ

What is the fundamental rating for PACS stock?

ChartMill assigns a fundamental rating of 3 / 10 to PACS.


What is the valuation status of PACS GROUP INC (PACS) stock?

ChartMill assigns a valuation rating of 3 / 10 to PACS GROUP INC (PACS). This can be considered as Overvalued.


What is the profitability of PACS stock?

PACS GROUP INC (PACS) has a profitability rating of 4 / 10.


What is the valuation of PACS GROUP INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PACS GROUP INC (PACS) is 17.69 and the Price/Book (PB) ratio is 5.55.